Cabozantinib enhances CAIX specific CAR-T cells against renal cancer by improving effector functions and augmenting tumor immune microenvironment
Qihong Li(Xuzhou Medical College), Shishuo Sun(Xuzhou Medical College), Lin Yang(Second Affiliated Hospital of Jilin University), Wanxin Zhao(Xuzhou Medical College), Junnian Zheng(Xuzhou Medical College), Qing Zhang(South China University of Technology), Ying Xue(Xuzhou Medical College), Shuyu Li(Xuzhou Medical College), Jingwei Tang(Xuzhou Medical College), Zhuyu Lu(Xuzhou Medical College), Xiaoge Gao(Xuzhou Medical College)
Cited by 6
Related Papers
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
|Journal of Immunology Research|2018|152
Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma
|Theranostics|2022|152
HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma
|Molecular Cancer Research|2007|148